Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Here's What Key Metrics Tell Us About Intuitive Surgical (ISRG) Q3 Earnings
Here's What Key Metrics Tell Us About Intuitive Surgical (ISRG) Q3 Earnings

For the quarter ended September 2025, Intuitive Surgical, Inc. (ISRG) reported revenue of $2.51 billion, up 22.9% over the same period last year. EPS came in at $2.40, compared to $1.84 in the

Middlefield Banc (MBCN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Middlefield Banc (MBCN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Middlefield Banc Corp. (MBCN) reported $19.89 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 18.3%. EPS of $0.65 for the same period compares to

United Community Banks (UCB) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
United Community Banks (UCB) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

United Community Banks (UCB) reported $276.85 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 13.2%. EPS of $0.75 for the same period compares to

Is It Worth Investing in Ross Stores (ROST) Based on Wall Street's Bullish Views?
Is It Worth Investing in Ross Stores (ROST) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Here's What Key Metrics Tell Us About Lennox (LII) Q3 Earnings
Here's What Key Metrics Tell Us About Lennox (LII) Q3 Earnings

Lennox International (LII) reported $1.43 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 4.8%. EPS of $6.98 for the same period compares to $6.68 a

Is It Worth Investing in Carvana (CVNA) Based on Wall Street's Bullish Views?
Is It Worth Investing in Carvana (CVNA) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

APTIV HLDS LTD (APTV) Is Considered a Good Investment by Brokers: Is That True?
APTIV HLDS LTD (APTV) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Travel  Leisure Co. (TNL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Travel Leisure Co. (TNL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Travel + Leisure Co. (TNL) reported $1.04 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 5.1%. EPS of $1.80 for the same period compares to $1.57

Compared to Estimates, Amphenol (APH) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Amphenol (APH) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Amphenol (APH) reported revenue of $6.19 billion, up 53.4% over the same period last year. EPS came in at $0.93, compared to $0.50 in the year-ago quarter.

The

Brokers Suggest Investing in AudioEye (AEYE): Read This Before Placing a Bet
Brokers Suggest Investing in AudioEye (AEYE): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Wall Street Bulls Look Optimistic About Quanta Services (PWR): Should You Buy?
Wall Street Bulls Look Optimistic About Quanta Services (PWR): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Northern Trust (NTRS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Northern Trust (NTRS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2025, Northern Trust Corporation (NTRS) reported revenue of $2.03 billion, up 2.9% over the same period last year. EPS came in at $2.29, compared to $1.96 in the

Wall Street Analysts Think SentinelOne (S) Is a Good Investment: Is It?
Wall Street Analysts Think SentinelOne (S) Is a Good Investment: Is It?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Compared to Estimates, CME (CME) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, CME (CME) Q3 Earnings: A Look at Key Metrics

CME Group (CME) reported $1.54 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 3%. EPS of $2.68 for the same period compares to $2.68 a year ago.

Why Microsoft (MSFT) is a Top Stock for the Long-Term
Why Microsoft (MSFT) is a Top Stock for the Long-Term

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

One of our most popular

Earnings Growth & Price Strength Make Walt Disney (DIS) a Stock to Watch
Earnings Growth & Price Strength Make Walt Disney (DIS) a Stock to Watch

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Is JPMorgan Chase & Co. (JPM) a Buy as Wall Street Analysts Look Optimistic?
Is JPMorgan Chase & Co. (JPM) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Matador Q3 Earnings & Revenues Beat on Higher Production Volumes
Matador Q3 Earnings & Revenues Beat on Higher Production Volumes

Matador Resources Company MTDR reported third-quarter 2025 adjusted earnings of $1.36 per share, which beat the Zacks Consensus Estimate of $1.22. However, the bottom line declined from the year-ago

Hilton Q3 Earnings Surpass Estimates, Revenues Rise Y/Y, Stock Up
Hilton Q3 Earnings Surpass Estimates, Revenues Rise Y/Y, Stock Up

Hilton Worldwide Holdings Inc. HLT reported third-quarter 2025 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate. The top and bottom lines increased on a year-over-year

Barrick Mining vs. Newmont: Which Gold Giant Shining Brighter Now?
Barrick Mining vs. Newmont: Which Gold Giant Shining Brighter Now?

Barrick Mining Corporation B and Newmont Corporation NEM are two of the biggest gold mining companies on the planet, each with extensive operations across multiple continents and diversified

The Zacks Analyst Blog Highlights Apple, Meta Platforms, JPMorgan Chase and AstroNova
The Zacks Analyst Blog Highlights Apple, Meta Platforms, JPMorgan Chase and AstroNova

For Immediate Release

Chicago, IL – October 22, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

CEG Outperforms Its Industry in 6 Months: How to Play the Stock?
CEG Outperforms Its Industry in 6 Months: How to Play the Stock?

Shares of Constellation Energy Corporation (CEG) have rallied 79.2% in the past six months compared with the Zacks Alternative Energy – Other industry’s growth of 48%. CEG continues to add clean

BDTX vs. ORIC: Which Oncology Focused Biotech Stock Is a Better Pick Now?
BDTX vs. ORIC: Which Oncology Focused Biotech Stock Is a Better Pick Now?

Black Diamond Therapeutics, Inc. BDTX is a clinical-stage oncology company developing therapies that target families of oncogenic mutations in patients with cancer.

ORIC Pharmaceuticals ORIC is also

Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up
Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up

Boston Scientific Corporation BSX posted third-quarter 2025 adjusted earnings per share (EPS) of 75 cents, up 19% from the year-ago figure. The figure beat the Zacks Consensus Estimate by 5.6% and

Enphase Energy to Report Q3 Earnings: Here's What to Expect
Enphase Energy to Report Q3 Earnings: Here's What to Expect

Enphase Energy, Inc. ENPH is scheduled to release its third-quarter 2025 results on Oct. 28, after market close.In the last reported quarter, the company delivered an earnings surprise of 11.29%